Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.
<h4>Background</h4>Clinical inertia has been defined as mistakes by the physician in starting or intensifying treatment when indicated. Inertia, therefore, can affect other stages in the healthcare process, like diagnosis. The diagnosis of dyslipidemia requires ≥2 high lipid values, but...
Main Authors: | Antonio Palazón-Bru, Vicente F Gil-Guillén, Domingo Orozco-Beltrán, Vicente Pallarés-Carratalá, Francisco Valls-Roca, Carlos Sanchís-Domenech, José M Martín-Moreno, Josep Redón, Jorge Navarro-Pérez, Antonio Fernández-Giménez, Ana M Pérez-Navarro, José L Trillo, Ruth Usó, Elías Ruiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24626597/?tool=EBI |
Similar Items
-
Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia
by: Trillo Jose L, et al.
Published: (2010-11-01) -
Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study
by: Jorge Navarro-Pérez, et al.
Published: (2018-09-01) -
Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.
by: Domingo Orozco-Beltran, et al.
Published: (2017-01-01) -
Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.
by: Domingo Orozco-Beltran, et al.
Published: (2018-01-01) -
Overview of guidelines for the management of dyslipidemia: EU perspectives
by: Giner-Galvañ V, et al.
Published: (2016-09-01)